Ocular Surgery News

The content you need, when you need it.

[Ocular Surgery News @Healio_OSN]

#CataractSurgery in highly myopic #eyes presents distinct challenges that require:

✅Careful planning.
✅Surgical technique adjustment.
✅Close postoperative management.

Dr. Uday Devgan offers a full roadmap on @GoHealio: 🔗

https://t.co/gSuMlfc69l

@devgan

[Ocular Surgery News @Healio_OSN]

Your peers are asking about the DEWS III report. 👁️

Don’t get left behind. Ask about it now: https://t.co/fzDdIsBNr7

[Ocular Surgery News @Healio_OSN]

‼️New data‼️

#Lisraya, an oral TYK2/JAK1 inhibitor, achieved its primary endpoint in two phase 3 clinical trials investigating it for the treatment of noninfectious #uveitis.

Read more on @GoHealio:🔗

https://t.co/mwrbK4HAls

[Ocular Surgery News @Healio_OSN]

One question can lead to so much more. Explore related questions, create patient handouts and personalize your Healio AI experience with every interaction.👉 https://t.co/reeEqa6KuC

#HealioAI #ClinicalAI

[Ocular Surgery News @Healio_OSN]

‼️From #AAO2026‼️

Determining the dominant #eye should be one part of #monovision planning but not the deciding rule on eye assignment.

Read more: 🔗

https://t.co/fuHb5ek19T

@aao_ophth

[Ocular Surgery News @Healio_OSN]

“The advantage of #Enspryng is that this is its second indication, and it has a well-established safety profile.”

Chris Brittain, of @Genentech, spoke with @GoHealio about the #FDA approval of the first at-home treatment for #ThyroidEyeDisease. 🔗

https://t.co/iVQSBVrNPI

[Ocular Surgery News @Healio_OSN]

For many #ophthalmologists, now may be the perfect time to go #digital in the OR.

Why? Dr. John Hovanesian outlines 6️⃣ reasons. 👀

Read now on @GoHealio!: 🔗

https://t.co/Mhvo46eP2X

[Ocular Surgery News @Healio_OSN]

Hot off the press:🔥

Alcon has acquired Neurotech Pharmaceuticals for $550 million plus contingent payments based on commercial milestones.

Read more: 🔗

https://t.co/zxvxmzlT6c

#Vision #Ophthalmology

[Ocular Surgery News @Healio_OSN]

‼️New on @GoHealio‼️

A phase 2 clinical trial investigating EC-104, a fluocinolone acetonide extended-release intravitreal implant for #DiabeticMacularEdema, met its primary endpoint.

Read more: 🔗

https://t.co/0i1i7K8WDa

[Ocular Surgery News @Healio_OSN]

🚨 The rules are simple: No Google, no ChatGPT, no Claude. Just you vs. WORD DOC. Think you can solve it?

Play now: https://t.co/UJ15fUkvN9

#WordChallenge #WORDDOC

[Ocular Surgery News @Healio_OSN]

INDUSTRY NEWS: 📣

#Duravyu for wet age-related macular degeneration fails to meet primary endpoint in phase 3 LUCIA trial.

Read more on @GoHealio:🔗
https://t.co/mxegZd0CNg

[Ocular Surgery News @Healio_OSN]

Every #ophthalmologist is vulnerable to repetitive strain injury.

To sustain a long and rewarding career, management of both is critically important, according to Dr. Richard Lindstrom.

Read his key tips gathered across 5 decades as a busy surgeon: 🔗

https://t.co/acQINQWjOG

[Ocular Surgery News @Healio_OSN]

🔥 New episode of Mend the Gap 🔥In this episode live from the #WIOSummerSymposium Laura B. Enyedi, MD, sits down with @SophieBakriMD and Michelle T. Cabrera, MD, to discuss their experiences in leadership roles. Listen here 🎧https://t.co/N1FYqknxMV

[Ocular Surgery News @Healio_OSN]

#Diet, cardiovascular health and social factors can impact #glaucoma risk.

Read more from @GoHealio's coverage of #AAO2026:🔗

https://t.co/jjOvJrJvJx

@aao_ophth

[Ocular Surgery News @Healio_OSN]

After years of repetitive movements as a #surgeon, it's not easy to fix damage to the body.

That is why it is essential for younger #doctors to prioritize healthy #ergonomic habits.

Dr. Sam Garg shares tips and tricks for combatting pain in the OR:🔗
https://t.co/kshYrDfI29

[Ocular Surgery News @Healio_OSN]

“These are tough patients that we now have more insights on maybe using a long-acting depot drug like fluocinolone 0.18 mg.”

Dr. David Almeida discusses fluocinolone acetonide 0.18 mg for noninfectious posterior segment #uveitis.

Read more: 🔗

https://t.co/9iwN9ybanm

[Ocular Surgery News @Healio_OSN]

For #ophthalmologists, occupational pain can start early.👀

In this @GoHealio exclusive feature, experts dive into how good #ergonomics can save doctors from all specialties from musculoskeletal pain and injuries.

Preserve your body for a long career!🔗

https://t.co/xSsz9qwWNK

[Ocular Surgery News @Healio_OSN]

‼️New Approval‼️

The #FDA approved a supplemental new drug application for #Ryzumvi, a preservative-free #EyeDrop, for the treatment of #presbyopia.

Find out more on @GoHealio:🔗
https://t.co/bGCMcrfIrM

[Ocular Surgery News @Healio_OSN]

In a new edition of Grand Rounds at New England Eye Center:

A 35-year-old woman was referred for a neuro-#ophthalmology evaluation for left optic disc edema and transient visual symptoms in the left #eye.

OCT was normal. Crack the case! 👀
https://t.co/hvGvyzvMLP

[Ocular Surgery News @Healio_OSN]

Bausch + Lomb named Thomas J. Appio interim CEO, replacing Brent Saunders.

@DarrellWhite provides commentary on what the move may suggest about Bausch + Lomb’s future.

Read more on @GoHealio: 🔗
https://t.co/pPuvzO1DUX